"GLP1R inhibits the progression of endometrial carcinoma through activation of cAMP/PKA pathway"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

This study strived to explore the role and mechanism of glucagon‐like peptide‐1 receptor (GLP1R) in endometrial carcinoma (EC). Click to show full abstract

This study strived to explore the role and mechanism of glucagon‐like peptide‐1 receptor (GLP1R) in endometrial carcinoma (EC).

Keywords: inhibits progression; endometrial carcinoma; progression endometrial; glp1r inhibits; carcinoma activation; carcinoma

Journal Title: Journal of Clinical Laboratory Analysis
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended